News Two-year Efficacy with Short-course Treatment Sets Mavenclad Apart, EMD Serono Executive Says

News 14 Notable Pilot Projects Among Research Efforts Funded by National MS Society

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: Do I Need Contrast Dye for an MRI?

Columns, Silver Linings - a Column by Jennifer Powell The DMT Decision: Tried and True or Shiny and New?

News Oligodendrocyte Precursor Cells Disrupt Blood-brain Barrier, Trigger Brain Inflammation in MS, Study Shows

News EMA Reviewing Safety Data for Lemtrada After Reports of Serious Treatment Side Effects

News National MS Society Grants $24.4M to Fund 64 MS Research Projects

News First Large-scale Clinical Genomic Research Study Aims to Improve Personalized MS Treatment

Columns, The MS Wire - A Column by Ed Tobias Cancer Medication Shows Promise in Treating Dangerous Brain Infection PML, Small-scale Study Finds

News Life Partners of RRMS Patients Experience High Strain Even in Early Disease Stages, Study Finds

News Trial Testing Deprexis Online Therapy for MS-related Depression Enrolling in US, Germany

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: MS Misdiagnoses, Mineral Intake Risk Study, Hormonal Changes, Rituximab and Vitamin D

News Web Portal That Detects Cognitive Changes via Language Tests Detailed in Study

News Anne Cross, Neurologist with Pioneering Work into B-cells and MS, Awarded John Dystel Prize

Columns, Fall Down, Get Up Again- a Column by John Connor The Drugs Do Work … Better Than My Right Hand

Columns, The MS Wire - A Column by Ed Tobias Immunocompromised? Watch Out for the C. Auris Fungus.

News TMEM10 in Demyelinated MS Lesions May Contribute to Remyelination, Study Suggests

News Excess Body Fat Spurs Disease Progression by Impact on Immune Cells, Study Suggests

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: What Is a Tremor?

Columns, Silver Linings - a Column by Jennifer Powell The Unlikely Warrior: Finding Purpose with SPMS

News Higher Vitamin D Levels in Rituximab-treated MS Patients Linked to Lower Inflammatory Activity, Study Suggests

News Tecfidera Better at Preventing Relapses than Aubagio, Real-world Study Suggests

News MS Misdiagnosis Too Common, Puts Patients in Unnecessary Peril from Therapies, Study Reveals

News Different Ways of Working Tailor Mayzent for Early SPMS Patients, Novartis Says

Columns, The MS Wire - A Column by Ed Tobias 3 Strategies for Dealing with the High Costs of Medications

News U.K. Implements Stricter Rules for Gabapentin, Pregabalin Prescriptions

News Menstruation Onset, Pregnancies and Breastfeeding Habits Don’t Influence MS Risk, Study Suggests

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: Mayzent Approval Surprises, Myelin Repair, Monitoring Nerve Inflammation

News In-Depth Study into MS Progression Gets $2M Boost from Roche Canada

News Mayzent ‘Will Change Lives’ of MS Patients Transitioning to SPMS, Novartis Says

A Life in Letters -- A Column By Jamie Hughes, Columns The Unplayable Piano

Columns, Fall Down, Get Up Again- a Column by John Connor Going Mobile

News #AAN2019 — Mineral Intake Not Linked to MS Risk, Study Suggests

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: What Can I Do About Tinnitus?

Columns, Silver Linings - a Column by Jennifer Powell Be the Change with Walk MS 2019

News #AAN2019 — Ibudilast Slows Brain Atrophy in PPMS But Not SPMS Patients, Phase 2b Trial Shows

News CMSC Announces Technology Contests to Improve MS Patients’ Quality Of Life

News Cleveland Clinic Neurologist Applauds Mayzent’s FDA Approval, But Surprised by Those It May Not Treat

News Veterans Affairs and National MS Society Team Up to Better Care for Vets with This Disease

News Review of 2 Diets That May Benefit MS Patients: A Nutritionist’s View

Columns, The MS Wire - A Column by Ed Tobias Mayzent Joins the MS Medication Arsenal, But I Have Questions

News Analysis of TWEAK Protein Levels May Help Identify Active Inflammation in MS Patients, Study Suggests

News NeurologyLive Launches Series of Educational Videos About MS

Columns, Faith of the Mustard Seed - a Column by Debi Wilson My Reluctant Journey Toward Using Mobility Devices

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: Reaction to SPMS DMT Approval, Ozanimod’s FDA Application, Caregiving Partnerships, a New Preventive Medication?

News Tiny DNA Molecule May Help Development of Myelin Repair Therapies, Study Suggests

News FDA Approves EMD Serono’s Mavenclad as Treatment for RRMS and Active SPMS

Columns, Fall Down, Get Up Again- a Column by John Connor Always in the Kitchen at Parties

Columns, The MS Wire - A Column by Ed Tobias Some Thoughts About Controlling Your MS Bladder

News $1.5M Earmarked for MS Research on Cannabis in Canada

News Mediaplanet Features MS Patient and Former NHL Player Bryan Bickell in Awareness Effort

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: What Exactly Is Cognition?

Columns, Silver Linings - a Column by Jennifer Powell Losing Fear of Change with SPMS

News MS Patient Groups React Favorably to Mayzent Approval, But Question Therapy’s Price Tag

Columns, Engaging Thoughts Is CBD Becoming Accepted as a Useful Product by the Mainstream?

News Fatigue is Normal When Caring for a Loved One with MS but it’s Unsustainable, Expert Says

News Celgene Seeking FDA Approval for Ozanimod to Treat Adults With Relapsing MS

News FDA Approves Novartis’ Mayzent for Relapsing Forms of Multiple Sclerosis, Including Active SPMS

News $1.5 Million Earmarked to Attract Neurologists, Improve Speciality Care in El Paso County

News AscellaHealth Highlights Support Program for MS Patients in Recognition of MS Awareness Month

News T20K in Good Position to Become Preventive MS Treatment, Cyxone Says

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: Walking Med Trial Recruiting, DMT Risk Tolerance, Sex and MS

News Body Mass Index, but Not Age at Puberty, Linked to Higher MS Risk, Study Suggests

News Physicians’ Education Resource Holds 2-Day Conference on Neurological Disorders Like MS in September

A Life in Letters -- A Column By Jamie Hughes, Columns Remember, Remember

Columns, Fall Down, Get Up Again- a Column by John Connor Singing the Bureaucracy Blues

Columns, The MS Wire - A Column by Ed Tobias Things to Know If You’re Thinking About Leaving Your Neurologist

News Phase 3 Trial of ADS-5102 Recruiting Participants of All MS Types

News Caregivers of MS Patients Should Not Neglect Own Needs, Expert Says in MSAA Webinar

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: Why Do I Have Facial Pain?

Columns, Silver Linings - a Column by Jennifer Powell Intimacy and MS: A Lesson in Discovery

News Roche and pan-Canadian Pharmaceutical Alliance Finalize Ocrevus Negotiations for RRMS and Early PPMS

News Schwann Cells Stop Blood-clotting Protein Thrombin from Damaging Nerves, Study Finds

Columns, Making a Difference - a Column by Cathy Chester. Dealing with Seizures and Multiple Sclerosis

News Beta-interferons Extend Survival of Relapsing MS Patients, Study Reports

News SPMS Treatment With Mayzent Better Than Best Supportive Care, ICER Report Says

Columns, The MS Wire - A Column by Ed Tobias DMT Choice for Your MS Is Your Decision

News Risk Tolerance for Therapies Linked to Age, Sex and Disability

News Sex and Intimacy Is Focus of MSAA Webinar

Columns, Faith of the Mustard Seed - a Column by Debi Wilson Dealing with MS Personality and Emotional Swings

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: Non-contrast MRIs, Stem Cell Study Seeks Subjects, Postpartum Relapses, Which DMT?

News Progressive MS Phase 2 Trial of NurOwn Stem Cell Therapy Enrolls 1st Patient

News Temelimab Provides Long-term Benefits in RRMS Patients, Extension Study Shows

Columns, Fall Down, Get Up Again- a Column by John Connor The Antibiotic Time Loop-the-Loop

Columns, The MS Wire - A Column by Ed Tobias Pediatric MS Can Be ‘Diagnostic Odyssey’

News Cleveland Clinic Nevada Joins DELIVER-MS Trial Assessing RRMS Treatments

News #AAN2019 — Ublituximab Safe, Well-tolerated in Extension Study of Phase 2 Trial in Relapsing MS

Columns, MS in Moderation, a column by Tamara Sellman Need to Know: What Is Chair Yoga?

News Non-contrast MRI Effective in Monitoring Progression of MS, Study Shows

News Fatty Acid Pentanoate May Be Effective Treatment for MS, Other Autoimmune Diseases, Mouse Study Suggests

News Phase 2 Trial Will Assess Autologous Mesenchymal Stem Cell Therapy to Treat Progressive Forms of MS

News On the Heels of New MS Prevalence Study, the National MS Society Marks MS Awareness Week with Patient Stories

Columns, Patiently Awakened - A Column by Teresa Wright-Johnson Visibly Me, Visible MS

Columns, The MS Wire - A Column by Ed Tobias Are MS Patients Using Too Many Medications?

News #AAN2019 – Risk of MS Relapses Not Increased Right After Giving Birth, Study Suggests

News Celgene Seeks Approval in European Union for Ozanimod to Treat Adult RRMS

Columns, Faith of the Mustard Seed - a Column by Debi Wilson What to Consider When Supplementing B Vitamins for MS Symptom Relief

Columns, The MS Wire - A Column by Ed Tobias MS News that Caught My Eye Last Week: A Cure for MS?, MS App, Robot for Balance, Botox for Spasticity

Aubagio, News Immunic Therapeutics Enrolls First Patient in Phase 2 Trial of IMU-838 for RRMS

News Tecfidera May Work to Lower Relapses by Inducing Epigenetic Changes in T-cells, Study Suggests